Based on the above results, we determined the targeting relationships and effects of miR-106a, miR-372-5p, E2F1, and NF-κB as downstream signaling molecules in drug-resistant liver cancer by using cell and animal models. The gene discussed is NFKB1; the disease is liver cancer.